A recent study published in the journal Clinical Ophthalmology revealed that combining scleral buckling with pars plana ...

3 This is because there is a higher risk of complications like scarring in the eye (Proliferative Vitreoretinopathy or PVR), and the lack of natural eye changes (Posterior Vitreous Detachment or PVD) ...

The epithelial–mesenchymal transition is the process by which polarised epithelial cells that are connected via adhesion lose their characteristics and acquire migratory and invasive properties ...

A team of ophthalmology researchers at Stanford University, working with a colleague from New York University School of Medicine, has found that despite promise for detecting diabetic retinopathy ...

In the LIGHTHOUSE study, Atsena Therapeutics is evaluating ATSN-201 gene therapy for X-linked retinoschisis, leveraging AAV.SPR capsid for central retina transduction without foveal detachment risks.

OCX-063 is under clinical development by OccuRx and currently in Phase I for Diabetic Retinopathy. According to GlobalData, Phase I drugs for Diabetic Retinopathy have a 78% phase transition success ...

Age-related macular degeneration (AMD) is the leading cause of vision loss in individuals over 65, characterized by abnormal changes in the macular, resulting in reduced vision and distorted objects.

Objective Randomised trials of type I anti-CD20 antibodies rituximab and ocrelizumab failed to show benefit in proliferative lupus nephritis (LN). We compared obinutuzumab, a humanised type II ...